Return-path: <response@response.hansonwade.com>
Envelope-to: amber@transocean.com
Delivery-date: Tue, 12 Jul 2016 07:05:26 -0700
Received: from e214.en25.com ([209.167.231.214]:39983)
	by vps.transocean.com with esmtps (TLSv1:DHE-RSA-AES256-SHA:256)
	(Exim 4.87)
	(envelope-from <response@response.hansonwade.com>)
	id 1bMyJN-00069z-Cc
	for amber@transocean.com; Tue, 12 Jul 2016 07:05:26 -0700
Received: from [10.4.1.245] ([10.4.1.245:58264] helo=P01SNJ012)
	by msm-mta08-tor6 (envelope-from <response@response.hansonwade.com>)
	(ecelerity 3.6.9.48312 r(Core:3.6.9.0)) with ESMTP
	id 59/6D-12794-6F8F4875; Tue, 12 Jul 2016 10:04:38 -0400
Message-ID: <2e2d3ce4b46345a89c07e644e7703be8@2622>
X-Binding: 2622
X-elqSiteID: 2622
X-elqPod: 0x04D4AA276AEFAC548AF4C2541180280C6E4E16410A533B620AAC2EC8FC2601D8
List-Unsubscribe: <http://s2622.t.en25.com/e/u?s=2622&elq=2e2d3ce4-b463-45a8-9c07-e644e7703be8>
MIME-Version: 1.0
From: "Farrah Ali" <info@hansonwade.com>
To: amber@transocean.com
Reply-To: "Hanson Wade" <info@hansonwade.com>
Date: 12 Jul 2016 10:04:00 -0400
Subject: Alison, did you see the deadline this Friday?
Content-Type: multipart/alternative;
 boundary=--boundary_3151987_24ca8c7a-4c95-4b7c-8e3c-1267eddf77b5
X-Spam-Status: No, score=2.7
X-Spam-Score: 27
X-Spam-Bar: ++
X-Ham-Report: Spam detection software, running on the system "vps.transocean.com",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 
 Content preview:  Hi Alison, The early bird deadline for the 4th Annual Advanced
    Pharma Analytics Summit expires this Friday (July 15th). This is your final
    opportunity to save up to $500 <http://www.advancedpharma-analytics.com/register/?utm_campaign=APA-6503-INT-EM16-Final%20EB&utm_medium=email&utm_source=Eloqua&elqTrackId=56B0A8C841110C40EBB391C1D4DB49F7&elq=2e2d3ce4b46345a89c07e644e7703be8&elqaid=12695&elqat=1&elqCampaignId=11109>.
    [...] 
 
 Content analysis details:   (2.7 points, 5.0 required)
 
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
 -0.0 RCVD_IN_DNSWL_NONE     RBL: Sender listed at http://www.dnswl.org/, no
                             trust
                             [209.167.231.214 listed in list.dnswl.org]
 -0.0 SPF_PASS               SPF: sender matches SPF record
  0.0 HTML_MESSAGE           BODY: HTML included in message
  1.0 HTML_FONT_FACE_BAD     BODY: HTML font face is not a word
 -0.0 BAYES_40               BODY: Bayes spam probability is 20 to 40%
                             [score: 0.2115]
  0.5 URIBL_GOLD             Contains an URL listed in the URIBL GOLDlist
                             [URIs: en25.com]
  1.0 URIBL_GREY             Contains an URL listed in the URIBL greylist
                             [URIs: en25.com]
  0.2 KAM_LOTSOFHASH         Emails with lots of hash-like gibberish
X-Spam-Flag: NO


----boundary_3151987_24ca8c7a-4c95-4b7c-8e3c-1267eddf77b5
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: base64
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----boundary_3151987_24ca8c7a-4c95-4b7c-8e3c-1267eddf77b5
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: 7bit

<!DOCTYPE html>
<html>
<head>
<!-- StartSystemHeader --><style>body{   } a img{border: none;}.ReadMsgBody { width: 100%;}.ExternalClass {width: 100%;}</style><!-- EndSystemheader --></head>
<body style=""><table align="left" width="7" height="3">
<tbody>
<tr>
<td align="centre"><br></td></tr></tbody></table><br>
 <table width="100%" border="0" cellspacing="0" cellpadding="0" class="email-body-wrapper"><tr><td align="center" height="0"></td></tr><tr><td>
<table cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" width="600" align="left" id="sc3364" style="table-layout: auto; empty-cells: show"><tr><td align="left" valign="top" width="1" id="empty0" style="font-size: 1px">&nbsp;</td><td valign="top" align="left" rowspan="1" colspan="2" width="597" id="view1" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word">
<div id="sc3456" class="sc-view hidden-border inline-styled-view editor-outline" style="left: 1px; width: 597px; top: 0px; color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word"><div class="co-border-style" style="">

<table width="597" height="100%" cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" class="co-style-table" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word; margin-top: 0px; margin-left: 0px; margin-right: 0px; margin-bottom: 0px"><tr><td valign="top" class="valign-able"><span class="remove-absolute"><div><span style="letter-spacing:0px;">Hi Alison</span>,</div><div><div><br></div><div>The
 early bird deadline for the <i>4th Annual Advanced Pharma Analytics Summit</i> <b>expires this Friday (July 15th)</b>. This is your final opportunity to&nbsp;<b><a href="http://www.advancedpharma-analytics.com/register/?utm_campaign=APA-6503-INT-EM16-Final%20EB&utm_medium=email&utm_source=Eloqua&elqTrackId=56B0A8C841110C40EBB391C1D4DB49F7&elq=2e2d3ce4b46345a89c07e644e7703be8&elqaid=12695&elqat=1&elqCampaignId=11109" data-targettype="webpage">save
 up to $500</a></b>.&nbsp;</div><div><br></div><div>Book
 your place today to tackle and discuss how you can effectively manage and leverage advanced data analytics to improve patient-centered outcomes and adopt a value-based treatment paradigm.</div><div><br></div><div>Learn from the latest case studies from the likes of <b>Genentech</b>,<b> FDA</b>, <b>Pfizer</b>, <b>EMD Serono</b>
 and many more who will demonstrate value and tangible ROI derived from effective data sourcing, standardization, integration, infrastructure, real-world evidence and advanced analytics.</div><div><br></div><div>Register online to receive the discounted rate: <b>
<a href="http://www.advancedpharma-analytics.com/register/?utm_campaign=APA-6503-INT-EM16-Final%20EB&utm_medium=email&utm_source=Eloqua&elqTrackId=C1E18317FF5725FB8CF15C153EEAF1C6&elq=2e2d3ce4b46345a89c07e644e7703be8&elqaid=12695&elqat=1&elqCampaignId=11109" data-targettype="webpage">www.advancedpharma-analytics.com/register/</a></b></div><div><br></div><div>Warm regards,</div><div>Farrah</div></div>
<div><br></div><div><b>Farrah Ali Ph.D</b></div><div><b>Senior Program Director,</b></div><div><b>Hanson
 Wade</b></div></span></td></tr></table></div></div></td><td align="left" valign="top" width="2" id="empty3" style="font-size: 1px">&nbsp;</td></tr><tr><td align="left" valign="top" width="1" id="empty4" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="214" height="12" id="empty5" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="383" height="12" id="empty6" style="font-size: 1px">&nbsp;</td>
<td align="left" valign="top" width="2" id="empty7" style="font-size: 1px">&nbsp;</td></tr><tr><td align="left" valign="top" width="1" id="empty8" style="font-size: 1px">&nbsp;</td><td valign="top" align="left" rowspan="1" colspan="1" width="214" id="view9" style="">
<div id="sc3464" class="sc-view" style="left: 1px; width: 214px; top: 384px; height: 61px"><div class="co-border-style" style="border-width: 2px; border-style: none">
<table width="214" height="100%" cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" class="co-style-table" style="margin-top: 0px; margin-left: 0px; margin-right: 0px; margin-bottom: 0px"><tr><td valign="top" class="valign-able"><a href="http://www.advancedpharma-analytics.com/?utm_campaign=APA-6503-INT-EM16-Final%20EB&utm_medium=email&utm_source=Eloqua&elqTrackId=FBD4B78D9E47F2A3A40E0D089CF64C40&elq=2e2d3ce4b46345a89c07e644e7703be8&elqaid=12695&elqat=1&elqCampaignId=11109" title="">
<img elqhref="http://www.advancedpharma-analytics.com/?elqTrackId=FBD4B78D9E47F2A3A40E0D089CF64C40" elqtitle="" data-targettype="webpage" width="214" height="61" src="http://img.en25.com/EloquaImages/clients/HansonWadeLtd/%7b75e21d60-70f8-40d7-a4fa-69e2a965d8a7%7d_7920_Advanced_Pharma_Analytics_US_2016_logo_v2.jpg" title="" alt="" id="sc3466" class="sc-view sc-image-view editor-outline sc-regular-size" style="display: block; cursor: pointer"></a></td></tr></table></div></div>
</td>
<td align="left" valign="top" width="383" id="empty10" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="2" id="empty11" style="font-size: 1px">&nbsp;</td></tr><tr><td align="left" valign="top" width="1" id="empty12" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="214" height="55" id="empty13" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="383" id="empty14" style="font-size: 1px">&nbsp;</td>
<td align="left" valign="top" width="2" id="empty15" style="font-size: 1px">&nbsp;</td></tr></table></td></tr><tr><td align="center" height="0"></td></tr></table> 
<font style="font-family: Arial; font-size: 10px;" face="">If you no longer wish to receive updates about this meeting <a title="Stop receiving emails about this meeting" href="http://s2622.t.en25.com/e/cu?s=2622&elqc=420&elq=2e2d3ce4b46345a89c07e644e7703be8">click here</a></font><br><font style="font-family: Arial; font-size: 10px;" face="">To
 unsubscribe from all further email communication from Hanson Wade <a title="Opt out of all Hanson Wade email communication" href="http://s2622.t.en25.com/e/u?s=2622&elq=2e2d3ce4b46345a89c07e644e7703be8">click here</a>. </font><br><font style="font-family: Arial; font-size: 10px;" face="">This email was sent to you at: </font><font style="font-family: Arial; font-size: 10px;" face="">amber@transocean.com</font><br><font style="font-family: Arial; font-size: 10px;" face="">
<a title="Hanson Wade" href="http://www.hansonwade.com/?utm_campaign=APA-6503-INT-EM16-Final%20EB&utm_medium=email&utm_source=Eloqua&elq=2e2d3ce4b46345a89c07e644e7703be8&elqCampaignId=11109">Hanson Wade</a> respects your <a title="Privacy Policy" href="http://hansonwade.com/privacy?utm_campaign=APA-6503-INT-EM16-Final%20EB&utm_medium=email&utm_source=Eloqua&elq=2e2d3ce4b46345a89c07e644e7703be8&elqCampaignId=11109">privacy</a></font><br><font style="font-family: Arial; font-size: 10px;">&copy;
 2012, Hanson Wade, 52 Grosvenor Gardens, London, SW1W 0AU</font>

<img src='http://s2622.t.en25.com/e/FooterImages/FooterImage1?elq=2e2d3ce4b46345a89c07e644e7703be8&siteid=2622' alt="" border=0 width=1px height=1px></body></html>
----boundary_3151987_24ca8c7a-4c95-4b7c-8e3c-1267eddf77b5--


